N-Side S.A.. (10/1/19). "Press Release: AstraZeneca Selects N-Side Suite for Clinical Trials to Optimize and Monitor Clinical Trial Supply Chain". Louvain-la-Neuve.

	Organisation	N-Side S.A.
	Group	N-Side (Group)
	Organisation 2	AstraZeneca plc (LSE: AZN)
	Group	AstraZeneca (Group)
	Product	N-Side Suite for Clinical Trials
	Product 2	clinical research
	Index term	AstraZeneca–N-Side: clinical supply chain management s/w, 201910– supply implementation of cloud-based N-Side Suite for Clincial Trials
	Person	Murray, John (AstraZeneca 201910 Supply Cahin Transformation Lead)
	Person 2	Parlongue, Jacques (MyCellHub 202212 CEO before N-Side 201910 CEO)

N-SIDE, provider of innovative software and strategic consulting services, announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Within the scope of this agreement, AstraZeneca will use specifically the N-SIDE Supply and Dashboard Apps in order to design, plan and monitor their clinical trial supply chain.

John Murray, Supply Chain Transformation Lead at AstraZeneca, commented: “N-SIDE’s Suite provides a tremendous opportunity for AstraZeneca to collaborate across key areas of clinical development and deliver the best studies for our patients."

Thanks to the N-SIDE Suite for Clinical Trials, AstraZeneca will achieve a centralization of their clinical supply chain management. The N-SIDE solution will support both strategic decision-making during protocol design as well as operational planning and change management of on-going trials. The business intelligence dashboards will be used for real-time trial monitoring, results visualization and supporting cross-department communication.

"We are proud to further our collaboration with AstraZeneca as they implement the N-SIDE Suite for Clinical Trials to manage their clinical supply chain” stated Jacques Parlongue, N-SIDE CEO. N-SIDE has provided consulting services for AstraZeneca clinical trial supply optimization since 2017.

The N-SIDE Suite for Clinical Trials is a cutting edge, cloud-based software that enables clinical trial managers to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk. With interconnected applications, the N-SIDE Suite for Clinical Trials uses advanced analytics, including optimization and machine learning, to support strategic and operational decision-making as well as facilitate trial monitoring with real-time data and knowledge sharing.

Ends

Notes to Editors

About N-SIDE

N-SIDE is an innovative software consulting company in advanced analytics designing optimization solutions for supply chain, operation and energy management. N-SIDE optimizes decisions of some of the largest companies around the world, across a vast range of industries including pharmaceuticals, chemicals, steel, pulp & paper and energy. N-SIDE uses cloud-based cutting-edge technologies and powerful algorithms, such as artificial intelligence and machine learning to solve the most complex industry challenges and turn them into opportunities. N-SIDE’s solutions empower organizations to make agile data-driven decisions to optimize processes and use resources wisely while efficiently managing risk and maximising profits. N-SIDE has been an active player in clinical trial supply forecasting and simulation for more than 15 years. To learn more, visit www.n-side.com.

For further information, please contact:

Corporate contact:
Sylvia Haller, Life Sciences Marketing Manager
N-SIDE
E: sha@n-side.com

Press Contact:
Deborah Cockerill / Juliette Craggs
Sciad Communications
E: n-side@sciad.com
T: +44 (0)20 3755 0571

Record changed: 2023-06-05